Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Hardy (Munich, Germany), A. Schneider (Munich, Germany), M. Frankenberger (Munich, Germany), A. Koch (Munich, Germany), K. Milger (Munich, Germany), C. Moulin (Brussels, Belgium), M. Fievez (Brussels, Belgium), C. Pilette (Brussels, Belgium), S. Meiners (Munich, Germany), I. Kammerl (Munich, Germany). LSC - 2019 - Validating immunoproteasome activity as a potential biomarker in non-invasive samples from COPD patients. 4100

Member's Comments

No comment yet.

Related content which might interest you: Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers Source: International Congress 2014 – Markers Year: 2014 Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Novel patterns of serum biomarkers profiling using minimal important clinical outcomes (MICO) in the longidutinal study BODE cohort of COPD patients Source: Annual Congress 2010 - COPD: symptoms and staging Year: 2010 Volumetric capnography in distinct phenotypes of COPD patients Source: International Congress 2016 – Lung function and imaging: new findings and new approaches Year: 2016 What is the best biomarker of COPD stability? Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Stable state MR-proadrenomedullin level in COPD patients; a validation study Source: International Congress 2014 – Comorbidities Year: 2014 Correlation between extracellular heat shock protein 72 and clinical parameters including exhaled oxygen level in COPD Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up Source: International Congress 2014 – Markers Year: 2014 Prediction of exercise capacity using impulse oscillation system in patients with COPD Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 Clinical phenotyping of COPD patients: a simple tool with prognosis value Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Is physical activity a determinant for change in FEV1 in COPD patients? A prospective cohort study Source: International Congress 2015 – Best abstracts in physical activity in chronic lung diseases Year: 2015 A network-based approach to defining phenotypes in COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Novel method of expressing serum biomarkers profiling in COPD patients: The heatmap-clinical pattern profile Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Microarray profiling of COPD patients versus non-COPD smokers reveals possible disease biomarkers Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Agreement of classification of COPD patients' physical activity with two activity monitors Source: Annual Congress 2013 –New insights in the assessment of physical activity in daily life in patients with COPD, asthmatics and smokers Year: 2013 Usefulness of respiratory impedance by measuring at functional residual capacity position Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015 Studying lung inflammatory biomarkers using non-invasive methods in patients with community acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002 Accurate and reliable determination of alpha1-antitrypsin levels in respiratory patients using dried blood spot specimens Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 Introducing a new prognostic instrument for long-term mortality prediction among COPD patients - the CADOT index. Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019